History proves time and time again that investing in companies pre-IPO is the fastest way to supercharge your wealth. In the past year, pre-IPO investors in Asana saw an 816% return... vs. just 35% for regular IPO investors. 
Pre-IPO investors in Airbnb made a 1,700% return... vs. just 122% for regular IPO investors. 
And pre-IPO investors in Snowflake banked a 2,650% return... vs. just 111% for regular IPO investors. 
It's clear that it pays to get in BEFORE a company goes public. Unfortunately, most folks have never had the chance. You used to have to be an accredited investor with strong connections to get in on these early private investments. Often, the minimum investment in these deals was as much as $100,000! Well, not anymore. Finally, you can get in some of the hottest IPOs of the year for as little as $10... with no red tape. What's more, you can do it in your regular brokerage account, IRA or 401(k). Today, you have a rare opportunity to get into a top private company before it goes public... It's the market leader in the potentially $3 trillion personalized medicine sector. Fortune magazine says it could "kick-start a personalized healthcare revolution." And Virgin Group founder Richard Branson says it's "absolutely transforming drug discovery." But here's the deal... This company could IPO as soon as Monday, June 14! Click here to see my colleague Andy Snyder's special broadcast before it's too late. Sincerely, Aviva
| 
No comments:
Post a Comment